United Statesbiobridgeglobal.org
BioBridge Global (BBG) is a U.S.-based nonprofit life sciences organization that supports the development and delivery of cell- and tissue-based therapies. Through subsidiaries including South Texas Blood & Tissue, QualTex Laboratories, GenCure, and BBG Advanced Therapies, the organization provides donor recruitment and management, collection (such as leukapheresis), laboratory testing, processing, storage, and distribution of human-derived starting materials and products.
BBG Advanced Therapies serves as a contract development and manufacturing organization (CDMO) for advanced therapy medicinal products (ATMPs), offering cGMP biomanufacturing and analytical services for cell and gene therapy programs. Operations follow quality systems aligned with FDA, EMA, and PMDA expectations, with capabilities that include assay development, cryopreservation, and controlled logistics. BioBridge Global supports biopharmaceutical developers seeking compliant supply chain, testing, and manufacturing pathways from early development through scale-up.
Also known as BBG.
None yet. When a new project in the record names BioBridge as owner, partner or investor, it shows here.
The partnership enhances global CDMO capacity, offering integrated services for ATMP development and manufacturing, leveraging expertise and infrastructure across the U.S. and Europe.
